Cargando…

Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer

Notch3 and pS6 play important roles in tumor angiogenesis. To assess the expression of Notch3 and pS6 in Chinese ovarian epithelial cancer patients, a ten-year follow-up study was performed in ovarian epithelial cancer tissues from 120 specimens of human ovarian epithelial cancer, 30 specimens from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhaoxia, Yun, Rongna, Yu, Xiaolin, Hu, Hui, Huang, Genhua, Tan, Buzhen, Chen, Tingtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944072/ https://www.ncbi.nlm.nih.gov/pubmed/27445438 http://dx.doi.org/10.1155/2016/5953498

Ejemplares similares

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019)

GTW inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer via ILK/AKT/GSK3β/Slug Signalling Pathway
por: Feng, Ying, et al.
Publicado: (2021)

Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023)

Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer
por: Hu, Hui, et al.
Publicado: (2016)

Revealing the Disturbed Vaginal Micobiota Caused by Cervical Cancer Using High-Throughput Sequencing Technology
por: Xie, Yupei, et al.
Publicado: (2020)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma
por: Xu, Lu, et al.
Publicado: (2019)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
por: Liu, Longyang, et al.
Publicado: (2019)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer
por: Wang, Lishuang, et al.
Publicado: (2015)

SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer
por: Váncza, Lóránd, et al.
Publicado: (2023)

Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
por: Xu, Xue-lian, et al.
Publicado: (2017)

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer
por: Liu, Longyang, et al.
Publicado: (2022)

14-3-3ζ Overexpression is Associated with Poor Prognosis in Ovarian Cancer
por: Kim, Hyun-Jung, et al.
Publicado: (2018)

Overexpression of Karyopherin 2 in Human Ovarian Malignant Germ Cell Tumor Correlates with Poor Prognosis
por: He, Li, et al.
Publicado: (2012)

TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs
por: Le, Fuyin, et al.
Publicado: (2021)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

Overexpression of PRC1 indicates a poor prognosis in ovarian cancer
por: Bu, Hualei, et al.
Publicado: (2020)

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
por: Wen, Ning, et al.
Publicado: (2014)

Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
por: Li, Weiping, et al.
Publicado: (2012)

Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer
por: Liu, Shaoqiu, et al.
Publicado: (2021)

Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
por: Jiang, Senwei, et al.
Publicado: (2022)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway
por: Gao, Qi-Zhong, et al.
Publicado: (2020)

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma
por: Chen, Jie, et al.
Publicado: (2013)

SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer
por: Lou, Jiayan, et al.
Publicado: (2022)

Retracted: Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
por: Markers, Disease
Publicado: (2023)

Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment
por: Zhao, Xiumiao, et al.
Publicado: (2023)

Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis
por: Jackstadt, Rene, et al.
Publicado: (2019)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
por: Tjhay, Francisca, et al.
Publicado: (2015)

Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
por: Yang, Bikang, et al.
Publicado: (2017)

Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)

Overexpression of SEZ6L2 predicts poor prognosis in patients with cholangiocarcinoma
por: Wang, Ziming, et al.
Publicado: (2020)

Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma
por: Chiang, Ying-Cheng, et al.
Publicado: (2015)

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
por: Sun, Fei, et al.
Publicado: (2015)

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer
por: Ye, Qing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5khiecv4vskmjukldaf8c859da